- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Veeva Introduces New AI Capabilities
Veeva Systems introduced its new capability, Veeva Andi. It is a new artificial intelligence (AI) application that embeds tailored insights and suggestions into Veeva CRM for customer engagement.
In addition to Veeva Andi, Veeva announced new AI capabilities in Veeva CRM and Veeva Vault PromoMats. Veeva CRM Approved Notes leverages AI to help field reps build customer relationships and remain compliant with every interaction. The new capability allows field reps to capture free text notes in Veeva CRM and use AI to detect potential compliance risks.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
